Celldex Therapeutics, Inc.

CLDXNASDAQHealthcare● Active

$28.61

$-0.01(-0.03%)

Market Cap$1.9B

P/E Ratio—

52W High$35.79

52W Low$19.25

Avg Volume958K

Open$28.87

Beta0.93

Cash on Hand Financials Revenue

Celldex Therapeutics, Inc. (CLDX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CLDX · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$518.6M▼ -28.5% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$28.9M

cashAndCashEquivalents

Short-Term Investments

$489.7M

shortTermInvestments

YoY Change vs Prior Year

-28.5%

vs prior fiscal year

Latest Quarter

$451.5M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$518.6MCash on Hand

Total Debt$2.3MTotal Debt

Net Cash / Net Debt+$516.2MNet Cash Position

Cash vs Debt Ratio

Cash 100%Celldex Therapeutics, Inc. cash as % of market cap: 27.24%% · MCap $2BDebt 0%

Celldex Therapeutics, Inc. has a net cash position of $516.2M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$518.6M − $2.3M = +$516.2M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

CLDX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

CLDX cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$518.6M-28.5%

Dec 31, 2024FY$725.3M+72.0%

Dec 31, 2023FY$421.7M+38.3%

Dec 31, 2022FY$305.0M-25.3%

Dec 31, 2021FY$408.3M+110.0%

CLDX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

CLDX vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Celldex Therapeutics, Inc.YOU

CLDX

$518.6M$2B27.2%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Celldex Therapeutics, Inc. (CLDX) cash on hand as of December 31, 2025 is $518.6M, comprising $28.9M in cash and cash equivalents (CCE) plus $489.7M in short-term investments — reported as Celldex Therapeutics, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Celldex Therapeutics, Inc. cash reserves or cash position.

Celldex Therapeutics, Inc. annual cash on hand history shows decreased -28.5% in 2025: decreased -28.5% in 2025. Celldex Therapeutics, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Celldex Therapeutics, Inc. carries total debt of $2.3M against cash of $518.6M, resulting in a net cash position of +$516.2M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

CLDX cash on hand · 5 questions

As of December 31, 2025, Celldex Therapeutics, Inc. (CLDX) has $518,573,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $28,871,000 in cash and cash equivalents (CCE) plus $489,702,000 in short-term investments. Latest quarter (March 31, 2026): $451,458,000. Data sourced from the annual 10-K filing via FMP.

CLDX cash on handCLDX cash reservesCLDX cash 2025how much cash does CLDX have

▸ Source: FMP /balance-sheet-statement · US GAAP · Celldex Therapeutics, Inc. · Celldex Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025